An HPLC-MS/MS method for simultaneous determination of decitabine and its valyl prodrug valdecitabine in rat plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 15:917-918:78-83. doi: 10.1016/j.jchromb.2012.12.040. Epub 2013 Jan 9.

Abstract

A simple and sensitive HPLC-MS/MS method was developed and validated for the simultaneous determination of decitabine and valdecitabine in rat plasma. The analytes were separated on a C(18) column (150mm×4.6mm, 3.5μm) and a triple-quadrupole mass spectrometer equipped with an electrospray ionization (ESI) source was applied for detection. A clean solid-phase extraction procedure with cation exchange cartridge was employed to extract the analytes from rat plasma with high recovery of decitabine (>82%). The calibration curves were linear over a concentration range of 10-10,000ng/mL for decitabine and 5-500ng/mL for valdecitabine. The lower limit of quantitation (LLOQ) of decitabine and valdecitabine was 10 and 5ng/mL, respectively. The intra-day and inter-day precisions were less than 15% and the relative error (RE) was all within ±15%. The validated method was successfully applied to a pharmacokinetics study in rats after either decitabine or valdecitabine orally administrated to the Sprague-Dawley rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azacitidine / analogs & derivatives*
  • Azacitidine / blood
  • Azacitidine / chemistry
  • Azacitidine / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Decitabine
  • Linear Models
  • Male
  • Prodrugs / analysis*
  • Prodrugs / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Solid Phase Extraction
  • Tandem Mass Spectrometry / methods*
  • Valine / analogs & derivatives*
  • Valine / blood
  • Valine / chemistry
  • Valine / pharmacokinetics

Substances

  • Prodrugs
  • valdecitabine
  • Decitabine
  • Valine
  • Azacitidine